These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7695333)

  • 21. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model.
    Perrucci S; Fichi G; Buggiani C; Rossi G; Flamini G
    Parasitol Res; 2006 Jul; 99(2):184-8. PubMed ID: 16547730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves.
    Fayer R; Ellis W
    J Parasitol; 1993 Oct; 79(5):771-4. PubMed ID: 8410552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.
    Enriquez FJ; Riggs MW
    Infect Immun; 1998 Sep; 66(9):4469-73. PubMed ID: 9712802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of alpha-cyclodextrin against experimental cryptosporidiosis in neonatal goats.
    Castro-Hermida JA; Pors I; Otero-Espinar F; Luzardo-Alvarez A; Ares-Mazás E; Chartier C
    Vet Parasitol; 2004 Feb; 120(1-2):35-41. PubMed ID: 15019141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling the onset of natural cryptosporidiosis in calves with paromomycin sulphate.
    Grinberg A; Markovics A; Galindez J; Lopez-Villalobos N; Kosak A; Tranquillo VM
    Vet Rec; 2002 Nov; 151(20):606-8. PubMed ID: 12463536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptosporidium parvum: oocyst excretion and viability patterns in experimentally infected lambs.
    Bukhari Z; Smith HV
    Epidemiol Infect; 1997 Aug; 119(1):105-8. PubMed ID: 9287951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic use of decoquinate for infections with Cryptosporidium parvum in experimentally challenged neonatal calves.
    Moore DA; Atwill ER; Kirk JH; Brahmbhatt D; Herrera Alonso L; Hou L; Singer MD; Miller TD
    J Am Vet Med Assoc; 2003 Sep; 223(6):839-45. PubMed ID: 14507102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
    Li X; Brasseur P; Agnamey P; Leméteil D; Favennec L; Ballet JJ; Rossignol JF
    Folia Parasitol (Praha); 2003 Mar; 50(1):19-22. PubMed ID: 12735719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.
    Riggs MW; Cama VA; Leary HL; Sterling CR
    Infect Immun; 1994 May; 62(5):1927-39. PubMed ID: 8168959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-linked immunosorbent assay for the detection of Cryptosporidium parvum IgG in the serum of cats.
    Lappin MR; Ungar B; Brown-Hahn B; Cooper CM; Spilker M; Thrall MA; Hill SL; Cheney J; Taton-Allen G
    J Parasitol; 1997 Oct; 83(5):957-60. PubMed ID: 9379309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy.
    Blanco-García E; Guerrero-Callejas F; Blanco-Méndez J; Gómez-Couso H; Luzardo-Álvarez A
    Eur J Pharm Sci; 2016 Sep; 92():74-85. PubMed ID: 27381880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of calves with a vaccine against Cryptosporidium parvum.
    Harp JA; Goff JP
    J Parasitol; 1995 Feb; 81(1):54-7. PubMed ID: 7876978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibody response in lambs naturally and experimentally infected with Cryptosporidium parvum.
    Ortega-Mora LM; Troncoso JM; Rojo-Vázquez FA; Gómez-Bautista M
    Vet Parasitol; 1993 Oct; 50(1-2):45-54. PubMed ID: 8291196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
    Baishanbo A; Gargala G; Duclos C; François A; Rossignol JF; Ballet JJ; Favennec L
    J Antimicrob Chemother; 2006 Feb; 57(2):353-5. PubMed ID: 16361328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum.
    Okhuysen PC; Chappell CL; Sterling CR; Jakubowski W; DuPont HL
    Infect Immun; 1998 Feb; 66(2):441-3. PubMed ID: 9453592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.
    Elliot BC; Wisnewski AV; Johnson J; Fenwick-Smith D; Wiest P; Hamer D; Kresina T; Flanigan TP
    Infect Immun; 1997 Sep; 65(9):3933-5. PubMed ID: 9284173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of oocysts and IgG antibodies to Cryptosporidium parvum in asymptomatic adult cattle.
    Lorenzo Lorenzo MJ; Ares-Mazás E; Villacorta Martínez de Maturana I
    Vet Parasitol; 1993 Mar; 47(1-2):9-15. PubMed ID: 8493772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.
    Tzipori S; Rand W; Griffiths J; Widmer G; Crabb J
    Clin Diagn Lab Immunol; 1994 Jul; 1(4):450-63. PubMed ID: 8556484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.